Sanofi will host an analyst meeting in Paris today to discuss the company’s Research and Development strategy, dev...
Singapore - In the first comprehensive analysis of clinical trial enrolment among older adults with blood cancers, resea...
US based biopharma company Juno Therapeutics has announced three license agreements to advance its program in multiple m...
Amgen has announced that following priority review of its supplemental Biologics License Application, the U.S. Food...
Jeong Woo Cho, Ph.D., has been appointed president and CEO of SK biopharmaceuticals and SK life science to lead the comp...
Singapore – Janssen Asia Pacific announced it has supported the establishment of the first-of-its-kind Asia Pacifi...
Biohaven Pharmaceutical Holding Company Ltd. has announced that the Company has received agreement from the U.S. Food an...
US based biotech company Biogen and pharma company Alkermes has announced that they have entered into a global lic...
Pharma company, GlaxoSmithKline and Innoviva has announced the filing of a supplemental New Drug Application (sNDA) with...
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX&r...
France based Step Pharma has announced the closing of a Series A financing totalling €14.5 million. Pontifax will ...
Singapore – RxSight (a US based medical devices company) announced that the U.S. Food and Drug Administration (FDA...
Japan based biopharma company PeptiDream Inc. has announced that it has entered into a multi-target discovery collaborat...
U.S. based Pharma Company Ionis Pharmaceuticals, Inc. has announced that it has licensed a second orally delivered Gener...
US based pharma company Cue Biopharma™, Inc. has announced a strategic strategic research collaboration and licens...
Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg after an approval from ...
Pharma company Lupin reported its financial performance for the second quarter ending September 30th, 2017. The company...
Pharma Major Lupin has received final approval for its Testosterone Topical Solution, 30 mg per actuation from the Unite...
